The Protection of Midazolam Against Immune Mediated Liver Injury Induced by Lipopolysaccharide and Galactosamine in Mice

Objectives: Liver macrophages agitated by Lipopolysaccharide (LPS) can enhance immuno-inflammatory responses in the liver which mediate liver injury and result in dysfunction. Midazolam has been reported to have inhibitory effects on activated immunity and escalated inflammation, however, what the e...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Pharmacol
Egile Nagusiak: Li, Jian, Tan, Hong, Zhou, Xiaona, Zhang, Chunpan, Jin, Hua, Tian, Yue, Zhao, Xinyan, Li, Xinmin, Sun, Xuelian, Duan, Meili, Zhang, Dong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2019
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6331471/
https://ncbi.nlm.nih.gov/pubmed/30670973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01528
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak